Poolbeg Pharma Pink Sheet Forward View - Relative Strength Index
| POLBF Pink Sheet | USD 0.06 -0.01 -14.45% |
Poolbeg Pharma's Relative Strength Index reference data reflects the model's output when applied to available daily price observations. This page summarizes the model output and key accuracy metrics for reference. The projected value and error metrics are calculated from available daily price observations.
The Relative Strength Index reference values for Poolbeg Pharma are derived from publicly available price data and should be used for informational purposes only. Relative Strength Index Analysis Today
Poolbeg Pharma PLC has current Relative Strength Index of 50.2.| Volatility | Backtest | Information Ratio |
Poolbeg Pharma Trading Date Momentum
| On March 27 2026 Poolbeg Pharma PLC was traded for 0.06 at the closing time. The highest daily price throughout the period was 0.06 and the lowest price was 0.06 . There was no trading activity during the period. Lack of trading volume on 03/27/2026 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
| Compare Poolbeg Pharma to competition |
Other Forecasting Options for Poolbeg Pharma
Relative Strength Index values for Poolbeg measure the speed and magnitude of recent price changes. Recognizing these clusters in Poolbeg Pharma's returns helps calibrate position size and stop-loss levels. Candlestick pattern analysis of Poolbeg Pink Sheet daily data can reveal short-term reversal or continuation signals.Poolbeg Pharma Related Equities
Checking Poolbeg Pharma against related firms within the Biotechnology space helps investors see where the stock stands among peers. Revenue and margin checks across this group help investors set expectations for Poolbeg Pharma's results. When Poolbeg Pharma breaks from its peer group on a key metric, it often signals a firm-level change worth exploring.
| Risk & Return | Correlation |
Poolbeg Pharma Market Strength Events
Market strength indicators provide a structured view of how Poolbeg Pharma pink sheet is positioned relative to trends. These indicators are valuable tools for identifying when to enter or exit positions in Poolbeg Pharma PLC. These signals help validate or refine position timing for Poolbeg Pharma.
| Rate Of Daily Change | 0.86 | |||
| Day Median Price | 0.0598 | |||
| Day Typical Price | 0.0598 | |||
| Price Action Indicator | -0.01 | |||
| Period Momentum Indicator | -0.01 | |||
| Relative Strength Index | 50.2 |
Poolbeg Pharma Risk Indicators
The analysis of Poolbeg Pharma's risk metrics is one of the most important steps in projecting its future price. This process quantifies the risk associated with Poolbeg Pharma's and helps determine how to manage it. A structured analysis of Poolbeg Pharma's risk indicators is one of the most reliable ways to improve forecast accuracy.
| Mean Deviation | 1.81 | |||
| Standard Deviation | 7.12 | |||
| Variance | 50.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Poolbeg Pharma
Coverage intensity for Poolbeg Pharma PLC matters because narrative visibility can influence sentiment, participation, and volatility around the name. This is most useful when investors want to understand why a security is suddenly drawing more public discussion.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
More Resources for Poolbeg Pink Sheet Analysis
Other Information on Investing in Poolbeg Pink Sheet
Financial ratios for Poolbeg Pharma organize key financial data into structured relationships. Values are aligned with the most recent reporting period available to us.